Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026)

Bausch Health Companies has disclosed Amortization of Deferred Charges across 18 years of filings, most recently posting $14.0 million for Q1 2026.

• Amortization of Deferred Charges for Q1 2026 came in at $14.0 million, down 6.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.0 million (up 66.07% YoY), and the FY2025 annual result was $94.0 million, up 70.91% from the prior year.
• Amortization of Deferred Charges came in at $14.0 million for Q1 2026 at Bausch Health Companies, down from $22.0 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $50.0 million in Q2 2022 to a low of $11.0 million in Q1 2023.
• The 5-year median for Amortization of Deferred Charges is $14.0 million (2022), against an average of $19.2 million.
• Across the five-year window, Amortization of Deferred Charges soared 316.67% in 2022 and tumbled 76.0% in 2023, its largest moves.
• Bausch Health Companies' Amortization of Deferred Charges stood at $13.0 million in 2022, then grew by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then surged by 57.14% to $22.0 million in 2025, then sank by 36.36% to $14.0 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $14.0 million (Q1 2026), $22.0 million (Q4 2025), and $16.0 million (Q3 2025), per Business Quant data.